Leadership

François Ravenelle, PhD

François Ravenelle, PhD Founder & CEO

Dr. Ravenelle is championing the comeback of cannabinoid receptor-1 (CB1) blockers at Inversago Pharma Inc. An entrepreneur with 16 years of industrial R&D experience,  his background includes pharmaceutical development from discovery through NDA approval.

Christine McCarthy, MD

Christine McCarthy, MD Acting Chief Medical Officer

Dr. McCarthy oversaw clinical development programs at Sanofi, including worldwide responsibility for rimonabant’s large Phase III program. Christine has more than 25 years of experience in large pharma companies.

Jean-Marie Vallet, PhD, MBA

Jean-Marie Vallet, PhD, MBA Acting Chief Business Development Officer

Dr. Vallet has over 30 years of experience in the pharma/biotech industry acquired across several functional areas including, Research, Business Development / Licensing, Strategic Planning, Corporate M&A and Finance & Administration.

Board of Directors

François Ravenelle, PhD

François Ravenelle, PhD Founder & CEO

Dr. Ravenelle is championing the comeback of cannabinoid receptor-1 (CB1) blockers at Inversago Pharma Inc. An entrepreneur with 16 years of industrial R&D experience,  his background includes pharmaceutical development from discovery through NDA approval.

Jamie Stiff, BSc, MBA

Jamie Stiff, BSc, MBA Managing Director, Genesys Capital

Mr. Stiff is Managing Director at Genesys Capital, a life science focused venture firm. Over his career, he has been responsible for investments in several early stage portfolio companies that cross a multitude of clinical disciplines and technology areas.

Maxime Ranger, PhD, MBA

Maxime Ranger, PhD, MBA General Partner, AmorChem

Dr. Ranger is a General Partner at AmorChem, an early-stage venture capital fund specialized in life science.  As a serial entrepreneur in the biotech industry, his expertise includes drug development across a range of therapeutic indications including oncology, hepatology, gastroenterology and metabolic conditions, such as NASH, Prader-Willi Syndrome, type-2 diabetes and obesity.  Dr. Ranger is a co-author of 30+ scientific publications in international peer-reviewed journals.